AGBL has signed with Euformatics

AGBL has signed an exclusive distribution agreement with the AGBL Group (Dubai, UAE) to offer validation, quality check and interpretation of NGS data to all our end users.

Euformatics is a Finnish biomedical software company that specialises in bioinformatics tools for genome data quality management and variant interpretation.

Their 3 main focus products are:-

• omnomicsV for NGS test validation
• omnomicsQ for internal quality control of NGS bioinformatics workflows
• omnomicsNGS for variant annotation, interpretation, and reporting

The CE-marked omnomicsNGS variant interpretation and reporting platform provides both independent clinicians and molecular genetics laboratories with all relevant genomic and variant information based on patient data, growing local knowledge, and external data sources.

Other features include:-

• Quick generation of gene panel reports according CAP/ACMG/ASCO guidelines
• Digs deep for rare genetic disorders in whole exomes or genomes
• Can use on the cloud or on local servers
• Can be integrated into larger IT infrastructures for clinical oncology or other genetic testing
• Enables collaboration and exchange of data at different scales; for clinical research projects or together with a biobank as a repository for genomic variants

The collaboration with Euformatics allows Alliance Global to help geneticists and clinicians interpret their NGS data and deliver laboratory reports for better and personalized treatments.

To find out more, email us at [email protected]